Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
ClinicalTrials.gov
MicrobiAr: Characterization and Follow-up of Microbiome and Health Indicators in Obese, Pre-Diabetes and Type 2 Diabetes Cohorts Undergoing a Plant-based Diet and Lifestyle Intervention
INTERVENTIONAL
Inicio: 30 de may de 2022
ID: NCT05372445
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 16 de ago de 2017
ID: NCT03242252
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec With or Without Metformin in Adults With Type 2 Diabetes (Onset® 9)
INTERVENTIONAL
Inicio: 19 de sept de 2017
ID: NCT03268005
Terminado
Fase 3
ClinicalTrials.gov
Inhaled Pre-prandial Human Insulin Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Chronic Obstructive Pulmonary Disease: A 52-week Open Label, Multicentre, Randomized, Parallel Trial to Investigate Long-term Safety
INTERVENTIONAL
Inicio: 15 de may de 2007
ID: NCT00472953
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 mg and 50 mg Compared With Placebo in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de nov de 2011
ID: NCT01456195
Reclutando
Fase 2
ClinicalTrials.gov
A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight
INTERVENTIONAL
Inicio: 17 de nov de 2023
ID: NCT06143956
Completado
Fase 2
ClinicalTrials.gov
A 12-week Randomized, Patient and Investigator Blinded, Placebo-controlled, Parallel Group Study to Investigate the Efficacy of LIK066 in Obese Patients With Non-alcoholic Steatohepatitis (NASH)
INTERVENTIONAL
Inicio: 4 de oct de 2017
ID: NCT03205150
Completado
Fase 3
ClinicalTrials.gov
Effect of Semaglutide 2.4 mg Once-weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction, and Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de jun de 2021
ID: NCT04916470
Desconocido
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00482950
Aún no recluta
ClinicalTrials.gov
Association Between Fatty Liver and Pancreatic Steatosis in Patients With Metabolic Syndrome
OBSERVATIONAL
Inicio: 1 de sept de 2025
ID: NCT06757348
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Parallel Group Safety, Efficacy, and Pharmacokinetics Study of BI 10773 (1 mg, 5 mg, 10 mg, 25 mg, and 50 mg) Administered Orally Once Daily Over 12 Weeks Compared Double Blind to Placebo With an Additional Open-label Sitagliptin Arm in Type 2 Diabetic Patients With Insufficient Glycemic Control Despite Metformin Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2008
ID: NCT00749190
Reclutando
ClinicalTrials.gov
Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood
OBSERVATIONAL
Inicio: 2 de may de 2019
ID: NCT05798676
Completado
Fase 4
ClinicalTrials.gov
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen.
INTERVENTIONAL
Inicio: 1 de nov de 2010
ID: NCT01204593
Completado
Fase 3
ClinicalTrials.gov
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
INTERVENTIONAL
Inicio: 20 de sept de 2013
ID: NCT01952145
Terminado
Fase 4
ClinicalTrials.gov
A 24 Weeks, Randomized, 2 Arms, Controlled, Multi-centre, National, Open-labeled, Parallel Study in Insulin naïve Patients With Type 2 Diabetes to Compare a Lantus Titration Algorithm vs. Physician's Standard Practice
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00627471
Completado
Fase 3
ClinicalTrials.gov
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00717457
Reclutando
Fase 3
ClinicalTrials.gov
CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
INTERVENTIONAL
Inicio: 5 de oct de 2023
ID: NCT05952557
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere /Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00309244
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
INTERVENTIONAL
Inicio: 9 de abr de 2025
ID: NCT06790693
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Three-Arm, Double-blind, Active Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Subjects Wtih Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00095030
Anterior
1
...
27
28
29
...
434
Siguiente
Filtros